A follow-on phase 2 trial of QBECO in moderate to severe Crohn's disease patients
Phase of Trial: Phase II
Latest Information Update: 03 Oct 2017
At a glance
- Drugs QBECO (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Sponsors Qu Biologics
- 03 Oct 2017 According to a Qu Biologics media release, the company expects to initiate this trial in the first quarter of 2018.
- 19 Apr 2017 According to a Qu Biologics media release, this trial is expected to begin in late 2017 or early 2018.
- 08 Mar 2017 New trial record